Kim; Ju Ryoung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Ju Ryoung.The latest application filed is for "novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease".

Company Profile

0.4.5

Kim; Ju Ryoung - Daejeon KR
Kim; Ju-Ryoung - Taejeon-si KR
Kim; Ju Ryoung - Yuseong-gu KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition and health food comprising extract of phellinus sp. PL3 or phellinsin A isolated from the same as an effective component for prevention and treatment of cardiovascular disease Grant 7,838,047 - Kim , et al. November 23, 2	2010-11-23
Abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,825,162 - Jeong , et al. November 2, 2	2010-11-02
Abietane diterpenoid compound, and composition comprising extract of Torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,820,212 - Jeong , et al. October 26, 2	2010-10-26
Abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease Grant 7,517,542 - Jeong , et al. April 14, 2	2009-04-14
Novel Abietane Diterpenoid Compound, And Composition Comprising Extract Of Torreya Nucifera, Or Abietane Diterpenoid Compounds Or Terpenoid Compounds Isolated From Them For Prevention And Treatment Of Cardiovascular Disease App 20090062384 - Jeong; Tae-Sook ; et al.	2009-03-05
Pharmaceutical Composition And Health Food Comprising Extract Of Phellinus Sp.pl 3 Or Phellinsin A Isolated From The Same As An Effective Component For Prevention And Treatment Of Cardiovascular Disease App 20090005440 - KIM; Sung Uk ; et al.	2009-01-01
Novel Abietane Diterpenoid Compound, And Composition Comprising Extract Of Torreya Nucifera, Or Abietane Diterpenoid Compounds Or Terpenoid Compounds Isolated From Them For Prevention And Treatment Of Cardiovascular Disease App 20080299238 - Jeong; Tae-Sook ; et al.	2008-12-04
Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease App 20070190192 - Jeong; Tae-Sook ; et al.	2007-08-16
Pharmaceutical composition and health food comprising extract of Phellinus sp. PL3 or phellinsin a isolated from the same as an effective component for prevention and treatment of cardiovascular disease App 20060115492 - Kim; Sung Uk ; et al.	2006-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.